DGAP-News: Analogic Plans to Accelerate Expansion Into Point-of-Care Market Upon Completion of Ultrasonix Acquisition
(firmenpresse) - Analogic Corporation
29.01.2013 20:40
---------------------------------------------------------------------------
Combination of BK Medical and Ultrasonix Builds Strong Ultrasound Product
Portfolio
PEABODY, Mass., 2013-01-29 20:40 CET (GLOBE NEWSWIRE) --
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and
aviation security technology, confirmed its support for the Ultrasonix product
line upon completion of the acquisition of Ultrasonix Medical Corporation, a
supplier of advanced ultrasound systems for point-of-care and general imaging
applications. Ultrasonix has over 5,000 systems installed worldwide, and would
bring key ultrasound products, technology, and sales channels that are
complementary to Analogic's ultrasound business.
'Once the acquisition is complete, Ultrasonix will be a significant contributor
to Analogic's Ultrasound Group,' said Farley Peechatka, senior vice president
and general manager, Global Ultrasound Business, Analogic. 'With a solid
installed base, superb portfolio of ultrasound products, unique GPS technology
for needle guidance, and intuitive graphical user interface, Ultrasonix will
help accelerate our presence and growth in point-of-care applications in
developed countries, and general imaging in emerging markets. We will continue
to improve and advance both the Ultrasonix and BK Medical product lines to
ensure that existing and new customers get the best products, support, and
service that we can offer.'
Analogic and Ultrasonix are recognized as two of the world's leading producers
of portable, procedure-driven, guided ultrasound technology. Founded in 2000,
Ultrasonix has a broad portfolio of both portable and cart-based ultrasound
systems with a recognized brand used primarily for point-of-care applications
such as emergency medicine, anesthesia, and reproductive medicine, as well as
general imaging in emerging markets. Analogic's BK Medical ultrasound solutions
are used to improve the practice of medicine in procedure-driven
markets--urology, surgery, and anesthesia. BK Medical's products, including its
award-winning Flex Focus(tm) family of systems and unique transducer designs,
offer advanced imaging capabilities that enable real-time image guidance in an
easy-to-use, portable platform.
'We are eager to bring these comprehensive and complementary product portfolios
together for an even stronger suite of advanced ultrasound systems for
customers of both companies,' said Lars Shaw, vice president of global
marketing at Analogic. 'In the point-of-care market, we believe our combined
Anesthesia product portfolio will be much stronger. We anticipate that
Ultrasonix will also complement our existing BK Medical urology and surgery
product portfolio for both the hospital and office-based practice. We will
continue to support Ultrasonix reproductive medicine customers with innovative
technologies. Ultrasonix general imaging products are targeted for fast
growing, emerging markets, which should allow us to better address emerging
markets with a strong product portfolio.'
The acquisition transaction is expected to close in late February 2013.
Forward-Looking Statements
Any statements about future expectations, plans, and prospects for the Company,
including statements containing the words ' believes,' ' anticipates,' '
plans,' ' expects,' and similar expressions, constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Actual results may differ materially from those indicated by such
forward-looking statements as a result of various important factors, including
risks relating to product development and commercialization, limited demand for
the Company's products, risks associated with competition, uncertainties
associated with regulatory agency approvals, competitive pricing pressures,
downturns in the economy, the risk of potential intellectual property
litigation, and other factors discussed in our most recent quarterly report
filed with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this presentation represent the
Company's views as of the date of this document. While the Company anticipates
that subsequent events and developments will cause the Company's views to
change, the Company specifically disclaims any obligation to update these
forward-looking statements. These forward-looking statements should not be
relied upon as representing the Company's views as of any later date.
About Analogic
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology
solutions to advance the practice of medicine and save lives. We are recognized
around the world for advanced imaging systems and technology that enable
computed tomography, ultrasound, digital mammography, and magnetic resonance
imaging (MRI), as well as automated threat detection for aviation security. Our
CT, MRI, digital mammography, and ultrasound transducer products are sold to
original equipment manufacturers (OEMs), providing state-of-the-art capability
and enabling them to enter new markets and expand their existing market
presence. Our market-leading BK Medical branded ultrasound systems are sold to
clinical end users through our direct sales force. For over 40 years we've
enabled customers to thrive, improving the health and enhancing the safety of
people around the world. Analogic is headquartered just north of Boston,
Massachusetts. For more information, visit www.analogic.com.
About Ultrasonix
Ultrasonix develops and manufactures diagnostic ultrasound imaging systems
designed to make ultrasound easy to use in more areas of patient care. The
company's customizable systems are built on an open software platform that
enables remote service and easy updates to keep current with advancements in
imaging technology. Founded in 2000, Ultrasonix is headquartered in Richmond,
British Columbia, Canada.
www.ultrasonix.com
Analogic is a registered trademark of Analogic Corporation.
The globe logo is a trademark of Analogic Corporation.
CONTACT: Investor Contact:
Mark Namaroff
Director of Investor Relations
(978) 326-4058
investorrelations(at)analogic.com
Media Contact:
Amy Cook
(925) 552-7893
amycook(at)amcpublicrelations.com
News Source: NASDAQ OMX
29.01.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Analogic Corporation
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US0326572072
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
analogic-plans-to-accelerate-expansion-into-point
of
care-market-upon-completion-of-ultrasonix-acquisition
Unternehmensinformation / Kurzprofil:
Datum: 29.01.2013 - 20:40 Uhr
Sprache: Deutsch
News-ID 224174
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 250 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Analogic Plans to Accelerate Expansion Into Point-of-Care Market Upon Completion of Ultrasonix Acquisition"
steht unter der journalistisch-redaktionellen Verantwortung von
Analogic Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
